期刊文献+

静脉输液港导管移位及血栓形成患者一例的护理 被引量:3

下载PDF
导出
摘要 植入式静脉输液港是一种植入皮下后可长期留在体内的静脉输液装置,主要由自带缝合硅胶树脂隔膜的注射座和不透射线的导管系统组成[1],可用于输注各种药物、补充液体、营养支持治疗、输血、血样采集等,可终身携带.对肿瘤患者来说,可以保证化疗方案有计划、按时、准确无误地进行,并且携带方便.但留置在静脉内的导管相对人体来说是一种异物,有些患者在留置导管期间会出现一些并发症,而关于输液港发生导管移位在国内却罕见报道.现将解放军空军总医院肿瘤内科收治的1例输液港植入后导管移位并导致颈内静脉血栓形成患者的护理体会报告如下.
作者 董雪 张玉珍
出处 《解放军护理杂志》 CSCD 2013年第5期56-57,共2页 Nursing Journal of Chinese People's Liberation Army
  • 相关文献

参考文献5

二级参考文献57

  • 1杜心平.下肢深静脉血栓形成静脉溶栓的护理进展[J].天津护理,2004,12(3):180-180. 被引量:9
  • 2吴剑辉,古静芬,黄慧嫦,苏仲玲,陈明远.植入式静脉输液港的应用及其管理[J].护理研究(中旬版),2005,19(12):2704-2705. 被引量:18
  • 3乔爱珍,马威,朱秋红.静脉输液港穿刺座冲洗量的体外实验[J].护理学杂志(综合版),2006,21(4):51-51. 被引量:20
  • 4韩文斌.中心静脉置管并发症的预防.国外医学:护理学分册,2003,22(12):567-561.
  • 5Boing AF,Rossi TF.Temporal trend in and spatial distributinn of lung cancer mortality in Brazil Between 1979 and 2004:magnitude,regional patterns,and gender-related differences.J Bras Pneumol,2007,33:544-551.
  • 6Prandoni P,Lensing AW,Piccioli A,et al.Recurrent venous thromboembolism andbleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.Blood,2002,100:3484-3488.
  • 7Biota JW,Doggen CJ,Osanto S,et al.Malignancies,prothrombotic mutations,and the risk of venous thrombosis.JAMA,2005,293:715-722.
  • 8Prandoni P,Falanga A,Piccioli A.Cancer and venous thromboembolism.Lancet Oncol,2005,6:401-410.
  • 9Bugge TH,Xiao Q,Kombrinck KW,et al.Fatal embryonic bleeding events in mice lacking tissue factor,the cellassociated initiator of blood coagulation.Proc Nail Acad Sci U S A,1996,93:6258-6263.
  • 10De Cicco M.The prothrombotic state in cancer:pathogenic mechanisms.Crit Rev Oncol Hematol,2004,50:187-196.

共引文献62

同被引文献62

  • 1Kumar A,Sharma R M,Jaideep C N,et al. Diagnosis of central venous catheter-related bloodstream infection without catheter removal: A prospective observational study[J].Med J Armed Forces India,2014,70(1) :17-21.
  • 2Picard M, Paqliuca S, Chiurazzi F, et al. Early ultrasono- graphic finding of septic thrombophlebitis is the main indicatorof central venous catheter removal to reduce infection-related mortality in neutropenic patients with bloodstream infection[J].Ann Oncol, 2012,23 (8) : 2122- 2128.
  • 3Rupam G, Chaitanya N, Vikas K, et al.Caltheter-related bloodstream infections[J].Int J Crit Illn Inj Sci, 2014,4 (2) : 162-167.
  • 4Lynn H.Keeping central line infection at bay[J].Nurs- ing, 2006,36 (4) : 58-75.
  • 5Sharpe E, Pettit J, Ellsbury D L.A national survey of neonatal peripherally inserted central catheter (PICC)praetices[J].Adv Neonatal Care, 2013,13 ( 1 ) : 55-74.
  • 6Gao Y,Liu Y,Ma X,et al.The incidence and risk factors of peripherally inserted central catheter-related infection among cancer patients[J].Ther Clin Risk Manag, 2015,5 (11) :863-871.
  • 7Amerasekera S S, Jonesa C M, Patela R, et al. Imaging of the complications of peripherally inserted central ve- nous catheters[J]. Clin Radiol, 2009,64 (8) : 832-840.
  • 8Baldinelli F, Capozzoli G, Pedrazzoli R, et al. Evaluation of the correct position of peripherally inserted central catheters:Anatomical landmark vs. electrocardiographic technique[J].J Vasc Access, 2015,6 (23) : 124-127.
  • 9Meinir E H. Reducing PICC migrations and improving patient outcomes[J]. Br J Nuts, 2 014,2 3 ( 2 ) : S12-S18.
  • 10Dioni E, Franceschini R, Mar2011o R, et al.Central vascu- lar catheters and infections[J].Earth Hum Dev,2014,90 (4) :51-53.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部